Uh-oh! This study is no longer available.
Moderate to Severe Plaque Psoriasis
PMG Research of Cary
18 or older
A research study is evaluating an investigational medication for moderate to severe plaque psoriasis.
This research study may be an option if you:
• Have a diagnosis or plaque psoriasis covering at least 10% of your body
• Have well controlled blood pressure
• Have not been treated with Otezla® (apremilast)
Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.
Qualified participants will receive all study-related care and study medication at no cost.
Patient Commitment Duration
Approximately 1 year
Financial compensation may be provided for time and travel expenses.
Number of visits in study
Approximately 18 clinic visits